Seeking Alpha

Seeking Alpha Portfolio App for iPad

154 people get ALPMF.PK articles and Market Currents by email alert.

Get email alerts on ALPMF.PK »

ALPMF.PK

Astellas Pharma Inc

5/20/2013, 9:39 AM ET

Quote & Headlines Market Currents StockTalk

alpmf chart

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

154 people get ALPMF.PK articles and Market Currents by email alert.

Get email alerts on ALPMF.PK »

HEADLINES:

ALL | PRO | FOCUS | RELATED | TRANSCRIPTS | NEWS & PR

Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Life Sciences Report • Fri, May 3 • 3 Comments
What Will It Take For Stem Cell Companies To Close The Valuation Gap?
Life Sciences Report • Wed, Apr 17 • 1 Comment
Medivation: Early Launch Of Xtandi Appears Solid
Biomed Group • Wed, Mar 6 • 9 Comments
IPO Preview: GlobeImmune
IPOdesktop • Wed, Sep 19, 2012
With Today's Licensing Deal, It's Time To Buy Vical Incorporated Before It's Too Late
Chris Katje • Thu, Sep 13, 2012 • 16 Comments
Disruptive Biotechnologies Stir Up Profits: Ray Blanco
Life Sciences Report • Mon, Aug 6, 2012 • 4 Comments
Dendreon: Who's That Knocking On Their Door?
Theodore Cohen • Sun, Jul 29, 2012 • 48 Comments
13 Healthcare Stocks With Major June Catalysts
Spencer Knight • Sun, Jun 3, 2012 • 10 Comments
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 2
StockPandit • Fri, May 25, 2012 • 1 Comment
Biotech-Focused Baker Bros. $3.7B Fund Bought These 3 Big Winners And Sold Others In Q1
GuruFundPicks • Thu, May 17, 2012 • 9 Comments
Investors Already Expect A Lot From Ariad Pharmaceuticals
Stephen Simpson • Mon, Apr 9, 2012 • 3 Comments
Analyzing Thursday's Noteworthy Insider Buys And Sells In Healthcare And Tech Sectors
GuruFundPicks • Fri, Feb 10, 2012
Biotech Stocks To Watch In 2012
Ohad Hammer • Mon, Feb 6, 2012 • 9 Comments
IPO Preview: Cempra Holdings
IPOdesktop • Wed, Feb 1, 2012 • 1 Comment
IPO Preview: Verastem
IPOdesktop • Wed, Jan 25, 2012 • 1 Comment
For Theravance Investors, GlaxoSmithKline Won't Be The Answer
EP Vantage • Wed, Jan 11, 2012 • 1 Comment
IPO Preview: NewLink Genetics
IPOdesktop • Tue, Nov 8, 2011
Encouraging Data Sends Medivation Soaring
The Burrill Report • Mon, Nov 7, 2011
Optimer Pharmaceuticals' Encouraging FDA News
Zacks Investment Research • Tue, Jul 5, 2011
Labeling and Script Use May Cause Problems For Optimer's New Drug
TheMarketFinancial • Thu, May 26, 2011 • 13 Comments

To learn more about Seeking Alpha Pro, click here.

Astellas Plans Sales Push in China
ChinaBio Today • Wed, May 26, 2010
Astellas Wins Approval for Overactive Bladder Treatment in China
ChinaBio Today • Tue, Dec 22, 2009
Astellas Proposes to Acquire CV Therapeutics for $1Billion
Eben Tessari • Tue, Jan 27, 2009 • 1 Comment

Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Life Sciences Report • Fri, May 3 • 3 Comments
What Will It Take For Stem Cell Companies To Close The Valuation Gap?
Life Sciences Report • Wed, Apr 17 • 1 Comment
Medivation: Early Launch Of Xtandi Appears Solid
Biomed Group • Wed, Mar 6 • 9 Comments
IPO Preview: GlobeImmune
IPOdesktop • Wed, Sep 19, 2012
With Today's Licensing Deal, It's Time To Buy Vical Incorporated Before It's Too Late
Chris Katje • Thu, Sep 13, 2012 • 16 Comments
Disruptive Biotechnologies Stir Up Profits: Ray Blanco
Life Sciences Report • Mon, Aug 6, 2012 • 4 Comments
Dendreon: Who's That Knocking On Their Door?
Theodore Cohen • Sun, Jul 29, 2012 • 48 Comments
13 Healthcare Stocks With Major June Catalysts
Spencer Knight • Sun, Jun 3, 2012 • 10 Comments
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 2
StockPandit • Fri, May 25, 2012 • 1 Comment
Biotech-Focused Baker Bros. $3.7B Fund Bought These 3 Big Winners And Sold Others In Q1
GuruFundPicks • Thu, May 17, 2012 • 9 Comments
Investors Already Expect A Lot From Ariad Pharmaceuticals
Stephen Simpson • Mon, Apr 9, 2012 • 3 Comments
Analyzing Thursday's Noteworthy Insider Buys And Sells In Healthcare And Tech Sectors
GuruFundPicks • Fri, Feb 10, 2012
Biotech Stocks To Watch In 2012
Ohad Hammer • Mon, Feb 6, 2012 • 9 Comments
IPO Preview: Cempra Holdings
IPOdesktop • Wed, Feb 1, 2012 • 1 Comment
IPO Preview: Verastem
IPOdesktop • Wed, Jan 25, 2012 • 1 Comment
For Theravance Investors, GlaxoSmithKline Won't Be The Answer
EP Vantage • Wed, Jan 11, 2012 • 1 Comment
IPO Preview: NewLink Genetics
IPOdesktop • Tue, Nov 8, 2011
Encouraging Data Sends Medivation Soaring
The Burrill Report • Mon, Nov 7, 2011
Optimer Pharmaceuticals' Encouraging FDA News
Zacks Investment Research • Tue, Jul 5, 2011
Labeling and Script Use May Cause Problems For Optimer's New Drug
TheMarketFinancial • Thu, May 26, 2011 • 13 Comments

There are no Transcripts on ALPMF.PK.

There are no News articles on ALPMF.PK.

ALPMF.PK vs. ETF Alternatives

Company Description

Currently, there's no company description for ALPMF.PK.

Sector: Healthcare

Industry: Drug Related Products

Country: United States